Evidence map›Paper›PMID 29298393›Full record

ArticleAmerican journal of respiratory and critical care medicine2018

Anti-Vascular Endothelial Growth Factor Antagonists: A Potential Primary Prevention for Bronchopulmonary Dysplasia?

Cindy T McEvoy, Manuel Durand

Open access · greenAbstract readEditorialComment
In one paragraph

Article in American journal of respiratory and critical care medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Cindy T McEvoy1 Department of Pediatrics Oregon Health and Science University Portland, Oregon and.
Manuel Durand2 Department of Pediatrics University of Southern California Keck School of Medicine Los Angeles, California.
Oregon Health & Science University · USUniversity of Southern California · US

Funding

Maternal vitamin C supplementation to decrease effects of smoking during pregnancy on infant lung function and health:Follow-up of 2 randomized trials and association with changes in DNA methylationUH3OD023288 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Cynthia T McEvoy, ELIOT R SPINDEL · 2018 to 2026
$12.1M
VitC to Decrease Effects of Smoking in Pregnancy on Infant Lung Function-CCC-LeadR01HL105447 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI MCEVOY, CYNTHIA T · 2012 to 2021
$9.8M
Maternal vitamin C supplementation to decrease effects of smoking during pregnancy on infant lung function and health:Follow-up of 2 randomized trials and association with changes in DNA methylationUG3OD023288 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI MCEVOY, CYNTHIA T, SPINDEL, ELIOT R · 2016 to 2024
$4.7M
CPAP Drives Lung Growth and Pulmonary Function in Moderately Preterm PrimatesR01HL129060 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI MCEVOY, CYNTHIA T, SPINDEL, ELIOT R · 2015 to 2019
$3.9M
NHLBI NIH HHS R01 HL105447NHLBI NIH HHS R01 HL129060NIH HHS UG3 OD023288
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bronchopulmonary DysplasiaFemaleHumansInfant, NewbornLungPregnancyPrimary PreventionVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-1

Identifiers

PMID29298393
PMCPMC5855076
OpenAlexW2781649746

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.